Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05KVC
|
||||
| Former ID |
DIB016461
|
||||
| Drug Name |
Paliroden
|
||||
| Synonyms |
SR-57667; SR-57667B
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 2 | [521794] | ||
| Company |
Sanofi-aventis
|
||||
| Formula |
C26H24F3N
|
||||
| Canonical SMILES |
C(F)(F)(c1cccc(c1)C1=CCN(CC1)CCc1ccc(cc1)c1ccccc1)F
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Glutamate receptor 2 | Target Info | Modulator | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||